Phage display engineered T cell receptors as tools for the study of tumor peptide-MHC interactions
Cancer immunotherapy has finally come of age, demonstrated by recent progress in strategies that engage the endogenous adaptive immune response in tumor killing. Occasionally, significant and durable tumor regression has been achieved. A giant leap forward was the demonstration that the pre-existing...
Main Authors: | Geir Åge Løset, Gøril eBerntzen, Terje eFrigstad, Sylvie ePollmann, Kristin Støen Gunnarsen, Inger eSandlie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00378/full |
Similar Items
-
Targeting the MHC Ligandome by Use of TCR-Like Antibodies
by: Lene Støkken Høydahl, et al.
Published: (2019-05-01) -
Expanding the versatility of phage display I: efficient display of peptide-tags on protein VII of the filamentous phage.
by: Geir Åge Løset, et al.
Published: (2011-01-01) -
Expanding the versatility of phage display II: improved affinity selection of folded domains on protein VII and IX of the filamentous phage.
by: Geir Åge Løset, et al.
Published: (2011-02-01) -
Stabilizing mutations increase secretion of functional soluble TCR-Ig fusion proteins
by: Lunde Elin, et al.
Published: (2010-08-01) -
Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA
by: Bogen Bjarne, et al.
Published: (2010-02-01)